116 related articles for article (PubMed ID: 6168365)
1. Vinblastine, infusion, bleomycin, and cis-dichlorodiammine-platinum chemotherapy in metastatic melanoma.
Nathanson L; Kaufman SD; Carey RW
Cancer; 1981 Sep; 48(6):1290-4. PubMed ID: 6168365
[TBL] [Abstract][Full Text] [Related]
2. Pilot study of vinblastine and bleomycin combinations in the treatment of metastatic melanoma.
Nathanson L; Wittenberg BK
Cancer Treat Rep; 1980 Jan; 64(1):133-7. PubMed ID: 6155208
[TBL] [Abstract][Full Text] [Related]
3. Randomized phase III trial of vinblastine, bleomycin, and cis-dichlorodiammine-platinum versus dacarbazine in malignant melanoma.
Luikart SD; Kennealey GT; Kirkwood JM
J Clin Oncol; 1984 Mar; 2(3):164-8. PubMed ID: 6199481
[TBL] [Abstract][Full Text] [Related]
4. Reduced platelet survival following chemotherapy with vinblastine, bleomycin and cis-platinum for testicular teratoma.
Rees GJ; Slade RR; Hopes P
Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1125-9. PubMed ID: 6186497
[TBL] [Abstract][Full Text] [Related]
5. Vinblastine, bleomycin, and cis-platinum for the treatment of metastatic malignant melanoma. National Cancer Institute of Canada Melanoma Group.
J Clin Oncol; 1984 Feb; 2(2):131-4. PubMed ID: 6199480
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin, vinblastine, and bleomycin in the treatment of metastatic melanoma: a phase II study of the Southeastern Cancer Study Group.
Johnson DH; Presant C; Einhorn L; Bartolucci AA; Greco FA
Cancer Treat Rep; 1985; 69(7-8):821-4. PubMed ID: 2410120
[TBL] [Abstract][Full Text] [Related]
7. Treatment of advanced malignant melanoma with vinblastine, bleomycin, and cisplatin.
Bajetta E; Rovej R; Buzzoni R; Vaglini M; Bonadonna G
Cancer Treat Rep; 1982 Jun; 66(6):1299-302. PubMed ID: 6177408
[TBL] [Abstract][Full Text] [Related]
8. Vinblastine, intermittent bleomycin, and single-dose cis-dichlorodiammineplatinum(II) in the management of stge III testicular cancer.
Bosl GJ; Kwong R; Lange PH; Fraley EE; Kennedy BJ
Cancer Treat Rep; 1980; 64(2-3):331-4. PubMed ID: 6157467
[TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy with vinblastine, bleomycin, and cis-diamminedichloroplatinum (II) in squamous cell carcinoma of the head and neck.
Brown AW; Blom J; Butler WM; Garcia-Guerrero G; Richardson MF; Henderson RL
Cancer; 1980 Jun; 45(11):2830-5. PubMed ID: 6155199
[TBL] [Abstract][Full Text] [Related]
10. PALA, vindesine, and cisplatin combination chemotherapy in advanced malignant melanoma. A pilot study.
Voigt H; Kleeberg UR
Cancer; 1984 May; 53(10):2058-62. PubMed ID: 6231091
[TBL] [Abstract][Full Text] [Related]
11. A phase II pilot trial of concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin 2, and interferon alpha-2B in patients with metastatic melanoma.
McDermott DF; Mier JW; Lawrence DP; van den Brink MR; Clancy MA; Rubin KM; Atkins MB
Clin Cancer Res; 2000 Jun; 6(6):2201-8. PubMed ID: 10873069
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy with cis-diammine-dichloro-platinum, vinblastine, and bleomycin in advanced testicular non-seminoma.
Stoter G; Sleijfer DT; Vendrik CP; Schraffordt Koops H; Struyvenberg A; Van Oosterom AT; Brouwers TM; Pinedo HM
Lancet; 1979 May; 1(8123):941-5. PubMed ID: 87614
[TBL] [Abstract][Full Text] [Related]
13. Pilot study of intra-arterial cisplatin and intravenous vinblastine and dacarbazine in patients with melanoma in-transit metastases.
Eton O; East M; Legha SS; Bedikian A; Buzaid AC; Papadopoulos N; Hodges C; Gianan M; Carrasco CH; Benjamin RS
Melanoma Res; 1999 Oct; 9(5):483-9. PubMed ID: 10596915
[TBL] [Abstract][Full Text] [Related]
14. Pilot study of preoperative chemotherapy with cisplatin, vinblastine, and dacarbazine in patients with local-regional recurrence of melanoma.
Buzaid A; Legha SS; Balch CM; Ross M; Ring S; Plager C; Papadopoulos NE; el-Naggar AK; Benjamin RS
Cancer; 1994 Nov; 74(9):2476-82. PubMed ID: 7923003
[TBL] [Abstract][Full Text] [Related]
15. A phase II trial of vinblastine, bleomycin, and cisplatin induction followed by dacarbazine and dibromodulcitol maintenance in the treatment of metastatic melanoma. A follow-up study of twenty-two patients.
Gentile PS; Epremian BE; Seeger J; Hamm JT; Sheth SP
Am J Clin Oncol; 1988 Dec; 11(6):666-8. PubMed ID: 2461074
[TBL] [Abstract][Full Text] [Related]
16. Variables for predicting serious toxicity (vinblastine dose, performance status, and prior therapeutic experience): chemotherapy for metastatic testicular cancer with cis-dichlorodiammineplatinum(II), vinblastine, and bleomycin.
Krikorian JG; Daniels JR; Brown BW; Hu MS
Cancer Treat Rep; 1978 Oct; 62(10):1455-63. PubMed ID: 81719
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study.
Wozniak AJ; Samson MK; Shah NT; Crawford ED; Ford CD; Altman SJ; Stephens RL; Natale RB; Bouroncle BA; Blumenstein BA
J Clin Oncol; 1991 Jan; 9(1):70-6. PubMed ID: 1702148
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin, vinblastine, and bleomycin as second-trial therapy in ovarian carcinoma. A pilot study of the Gynecologic Oncology Group.
Stehman FB; Ehrlich CE; Williams SD; Einhorn LH
Am J Clin Oncol; 1985 Feb; 8(1):27-31. PubMed ID: 2581434
[TBL] [Abstract][Full Text] [Related]
19. The use of BELD combination chemotherapy (bleomycin, vindesine, CCNU, and DTIC) in advanced malignant melanoma.
Young DW; Lever RS; English JS; MacKie RM
Cancer; 1985 May; 55(9):1879-81. PubMed ID: 2579722
[TBL] [Abstract][Full Text] [Related]
20. [A case of alpha-fetoprotein producing primary intracranial embryonal carcinoma treated with combination chemotherapy with cis-platinum, vinblastine and bleomycin (author's transl)].
Nakajima F; Pak S; Fujitsu K; Kuwabara T
No Shinkei Geka; 1981; 9(3):371-5. PubMed ID: 6165918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
